Check-Cap Overview
Check-Cap (CHEK) has a ROE of -731.71%, below the Healthcare sector average of 22.76%.
Get informed when a big investor buys or sells
+ Follow-731.71%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CHEK is -731.71%. That is below the Healthcare sector average of 22.76%. Investors often review this figure alongside Check-Cap's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, CHEK currently prints -731.71% for ROE, while the sector average sits near 22.76%. That is roughly 3314.3% below the sector mean. Large gaps often invite a closer look at Check-Cap's growth, margins, and balance sheet.
Return on Equity shows how effectively Check-Cap converts resources into returns. At -731.71%, CHEK may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CHEK's ROE (-731.71%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Check-Cap's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
